Inventor · disambiguated record
Victoria C. Schad
Also filed as: SCHAD VICTORIA C · SCHAD VICTORIA CAROL
5 granted patents·16 pending applications·236 citations·filing 1995–2010
85Inventor score
Files withXENOVA RES LTD12IMMULOGIC PHARMA CORP4SWAIN PHILIP A3CANTAB PHARMACEUTICALS RES LTD1IMMULOGIC INC1
Top patents by PatentIndex Score
21 records- 0190US5876727AHapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of sameIMMULOGIC PHARMA CORP·Filed 1996·Granted Mar 2, 1999·115 cites·18 claims
- 0280US5760184AHapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of sameIMMULOGIC PHARMA CORP·Filed 1995·Granted Jun 2, 1998·36 cites·8 claims
- 0378US5773003AHapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of sameIMMULOGIC INC·Filed 1995·Granted Jun 30, 1998·37 cites·12 claims
- 0472US5840307AHapten-carrier conjugates for use in drug-abuse therapy and methods for preparationIMMULOGIC PHARMA CORP·Filed 1995·Granted Nov 24, 1998·21 cites·3 claims
- 0568US2006286096A1Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of sameXENOVA RES LTD·Filed 2006·Application pending·0 cites
- 0668US2006280736A1Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of sameXENOVA RES LTD·Filed 2006·Application pending·0 cites
- 0768US2006286099A1Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of sameXENOVA RES LTD·Filed 2006·Application pending·0 cites
- 0868US2006286097A1Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of sameXENOVA RES LTD·Filed 2006·Application pending·0 cites
- 0968US2006286095A1Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of sameXENOVA RES LTD·Filed 2006·Application pending·0 cites
- 1068US2006280735A1Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of sameXENOVA RES LTD·Filed 2006·Application pending·0 cites
- 1167US6054127AHapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of sameIMMULOGIC PHARMA CORP·Filed 1997·Granted Apr 25, 2000·27 cites·7 claims
- 1267US2010105672A1Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of sameSWAIN PHILIP A·Filed 2009·Application pending·0 cites
- 1367US2010068222A1Hapten-carrier conjugates for use in drug abuse therapy and methods for preparation of sameSWAIN PHILIP A·Filed 2009·Application pending·0 cites
- 1464US2006286094A1Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of sameXENOVA RES LTD·Filed 2006·Application pending·0 cites
- 1564US2006058220A1Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of sameXENOVA RES LTD·Filed 2005·Application pending·0 cites
- 1663US2010209449A1Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of sameSWAIN PHILIP A·Filed 2010·Application pending·0 cites
- 1762US2005124061A1Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of sameXENOVA RES LTD·Filed 2003·Application pending·0 cites
- 1861US2006286098A1Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of sameXENOVA RES LTD·Filed 2006·Application pending·0 cites
- 1958US2006239997A1Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of sameXENOVA RES LTD·Filed 2006·Application pending·0 cites
- 2058US2002032316A1Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of sameCANTAB PHARMACEUTICALS RES LTD·Filed 2001·Application pending·0 cites
- 2153US2003069400A1Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of sameXENOVA RES LTD·Filed 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Victoria C. Schad files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →